Masterton, Robert <br/><br/>
The clinical positioning of telavancin in Europe.  [electronic resource] 

 -  International journal of antimicrobial agents  Mar 2015 
 - 213-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1872-7913 
<br/><br/><label>Standard No.: </label>10.1016/j.ijantimicag.2014.12.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminoglycosides--adverse effects<br/>Anti-Bacterial Agents--adverse effects<br/>Cross Infection--drug therapy<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Europe<br/>Gram-Positive Bacteria--drug effects<br/>Gram-Positive Bacterial Infections--drug therapy<br/>Humans<br/>Lipoglycopeptides